dc.contributor.author | Alnæs, Marie | |
dc.date.accessioned | 2021-02-18T13:19:47Z | |
dc.date.available | 2021-02-18T13:19:47Z | |
dc.date.created | 2020-08-11T11:40:23Z | |
dc.date.issued | 2020 | |
dc.Published | Clinical Case Reports. 2020, 1-3. | |
dc.identifier.issn | 2050-0904 | |
dc.identifier.uri | https://hdl.handle.net/11250/2728963 | |
dc.description.abstract | Anaphylaxis due to prick‐by‐prick testing is a rare but potentially life‐threatening complication. Personnel performing testing should be able to recognize and treat anaphylaxis. Adrenaline must be available. In high‐risk patients with a history of anaphylaxis, specific igE with components and a basophile activation test is desirable before skin prick testing. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Wiley | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.no | * |
dc.title | Anaphylaxis following prick-by-prick testing with peanut | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | Copyright 2020 The Authors. | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.doi | 10.1002/ccr3.3154 | |
dc.identifier.cristin | 1822702 | |
dc.source.journal | Clinical Case Reports | en_US |
dc.source.pagenumber | 2366-2368 | en_US |
dc.identifier.citation | Clinical Case Reports. 2020, 8 (12), 2366-2368. | en_US |
dc.source.volume | 8 | en_US |
dc.source.issue | 12 | en_US |